Cibus Inc. Company Profile

Background

Cibus Inc., founded in 2001 and headquartered in San Diego, California, is a leading agricultural biotechnology company specializing in the development and licensing of gene-edited plant traits. The company's mission is to enhance farming productivity and sustainability by creating plant traits that improve crop yields, reduce reliance on chemical inputs, and produce renewable, low-carbon plant products. Cibus operates primarily in the biotechnology research industry, focusing on major agricultural crops such as canola, rice, soybean, corn, and wheat.

Key Strategic Focus

Cibus' strategic focus centers on two main areas:

Productivity Traits: Developing traits that enable higher yields and reduce the use of crop protection chemicals and fertilizers.

Sustainable Ingredients: Creating plant-based ingredients that replace fossil fuel-based products, thereby reducing greenhouse gas emissions.

The company utilizes its proprietary Rapid Trait Development System™ (RTDS®) and Trait Machine™ to achieve these objectives, targeting primary markets in North America, South America, and Europe.

Financials and Funding

As of June 2025, Cibus has raised a total of $28 million in funding over eight rounds, with the latest round occurring on June 5, 2025, amounting to $28 million. The company's annual revenue is estimated to be between $50 million and $100 million.

On June 1, 2023, Cibus completed a merger with Calyxt, Inc., creating an industry-leading precision gene editing and trait development company. In connection with the merger, Cibus closed a $118.5 million private financing round.

Pipeline Development

Cibus has a pipeline of six productivity traits, including:

Pod Shatter Reduction (PSR) in Canola: Transferred to ten leading seed company customers, with elite germplasm editing underway.

Herbicide Tolerance Traits in Rice (HT1 and HT3): Transferred to leading rice seed companies for commercial development.

Sclerotinia (White Mold) Resistance: In advanced development stages, with successful initial greenhouse trials.

Nitrogen Use Efficiency: Aiming to reduce fertilizer use by enhancing nutrient processing efficiency.

These traits are at various stages of development, with anticipated commercialization timelines extending through 2027.

Technological Platform and Innovation

Cibus' innovation is driven by its proprietary RTDS® technology platform and the Trait Machine™, a semi-automated, crop-specific gene editing system. These platforms enable precise and predictable trait development directly in elite germplasm, significantly reducing the time and cost compared to conventional breeding methods. The Trait Machine™ is currently operational for canola, rice, and soybean, with plans to extend to wheat and corn by 2025.

Leadership Team

Rory Riggs: Chairman and Chief Executive Officer.

Peter Beetham: President and Chief Operating Officer.

Gerhard Prante: Vice Chairman.

These leaders bring extensive experience in biotechnology and agricultural innovation, guiding Cibus' strategic direction and operational execution.

Leadership Changes

In June 2023, following the merger with Calyxt, Inc., Rory Riggs assumed the roles of Chairman and Chief Executive Officer of the combined company. This leadership change aligns with Cibus' strategic vision to expand its operations and technological capabilities.

Competitor Profile

Market Insights and Dynamics

The agricultural biotechnology industry is experiencing significant growth, driven by the need for sustainable farming solutions and increased crop yields. Gene editing technologies are at the forefront of this transformation, offering precise and efficient methods for developing desirable plant traits.

Competitor Analysis

Cibus faces competition from several companies in the gene editing and agricultural biotechnology sectors, including:

Precision BioSciences: Specializes in gene editing technologies for agriculture and therapeutics.

Tropic Biosciences: Focuses on developing high-performance tropical crops through gene editing.

Caribou Biosciences: Engages in CRISPR-Cas9 gene editing for various applications, including agriculture.

These competitors are also leveraging advanced gene editing technologies to develop traits that enhance crop performance and sustainability.

Strategic Collaborations and Partnerships

Cibus has established significant collaborations to bolster its market position and innovation capacity:

Procter & Gamble (P&G): In Q1 2023, Cibus entered into a multi-year collaboration with P&G to develop sustainable, low-carbon ingredients, aligning with P&G's sustainability objectives.

John Innes Centre (JIC): In June 2025, Cibus announced an ongoing collaboration with JIC to introduce genetic mutations that enhance nutrient uptake, potentially reducing the need for artificial fertilizers.

Operational Insights

Cibus differentiates itself through its proprietary RTDS® technology and the Trait Machine™, enabling rapid and precise development of plant traits. This technological advantage allows Cibus to operate as an extension of seed company breeding programs, offering traits that are directly edited into elite germplasm. The company's focus on high-value productivity traits and sustainable ingredients positions it favorably in the competitive landscape.

Strategic Opportunities and Future Directions

Cibus is poised to capitalize on several strategic opportunities:

Expansion of Trait Machine™ Platforms: Plans to extend the Trait Machine™ to soybean, wheat, and corn by 2025 will broaden Cibus' market reach.

Commercialization of Pipeline Traits: Advancing the development and commercialization of its six productivity traits will enhance revenue streams.

Sustainable Ingredient Development: Collaborations with companies like P&G position Cibus to meet the growing demand for sustainable, plant-based ingredients.

By leveraging its technological platforms and strategic partnerships, Cibus aims to drive innovation and growth in the agricultural biotechnology sector.